FDA clears Deep Reasoning AI's NeuroDR neurovascular CT angiography software

Oct 27, 2026 · Issue 13 · 4 sources, 4 articles

Deep Reasoning AI and Innolitics have received FDA 510(k) clearance for NeuroDR, AI software designed for neurovascular CT angiography. The news was published on October 27.

Who is affected and how

doctor

Radiologists and neurologists may gain a new decision-support tool for acute vascular imaging.

medtech company

The 510(k) pathway remains viable for AI imaging software.

Sources

• Deep Reasoning AI and Innolitics Achieve FDA 510(k) Clearance for NeuroDR, AI Software for Neurovascular CT Angiographybusiness wire · Oct 27, 2026
• FDA clears Deep Reasoning AI’s NeuroDR for neurovascular CT scansmedical device network · Oct 28, 2026
• AI-enabled NeuroDR software for neurovascular imaging gains US FDA 510(k) clearanceneuronews international · Oct 28, 2026
• FDA clears Deep Reasoning AI's neurovascular CTA softwareauntminnie · Oct 28, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.